Overview

Effects of Labetalol on Nicotine Administration in Humans - 14

Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborators:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Treatments:
Labetalol
Nicotine